Section heads: Konrad Rejdak, Poland; Tetyana Litovchenko, Ukraine | |||
1 hour | Debate: Are generics equally effective and safe as original AEDs | ||
Capsule: Generics used extensively in different countries. For patients with epilepsy, the rules for using generic drugs have their own requirements. | |||
10 min | Debate host: Ilan Blatt, Israel | ||
15 min | Yes: Taras Studenyak, Ukraine | ||
15 min | No: Ludmila Tantsura, Ukraine | ||
20 min | Discussion and rebuttals | ||
1 hour | Debate: Are new generation AEDs superior to the classical antiepileptic drugs in the management of epilepsy? | ||
Capsule: Over the past 30 years, the number of AED has increased more than 3-fold. Many of them have been clinically tested as first-line therapy. However, the proportion of pharmacoresistant patients remains the same. Is it appropriate to designate "new" AED as first-line therapy? | |||
10 min | Debate host: Lidiya Maryenko, Ukraine | ||
15 min | Yes: Ilan Blatt, Israel | ||
15 min | No: Yurii Horansky, Ukraine | ||
20 min | Discussion and rebuttals | ||
1 hour | Lunch Break | ||
1 hour | Debate: Should we always initiate treatment after first ever epileptic seizure? | ||
Capsule: According to the new definition of epilepsy, the diagnosis of epilepsy is always needed after 2 unprovoked seizures. In what cases is it possible to diagnose epilepsy and start treatment after a first seizure? | |||
10 min | Debate host:Tetyana Litovchenko, Ukrain | ||
15 min | Yes: Konrad Rejdak, Poland | ||
15 min | No: Volodymyr Kharytonov, Ukraine | ||
20 min | Discussion and rebuttals | ||
1 hour | Debate: The controversies of post-stroke epilepsy: diagnosis and clinical guidance | ||
Capsule: Should we consider the first attack of post-stroke seizures as a debut of epilepsy? When should we start administration of antiepileptic drugs and what medication should be chosen? | |||
10 min | Debate host: Konrad Rejdak, Poland | ||
15 min | Yes:Yuriy Vorokhta, Ukraine | ||
15 min | No: Denys Khramtsov, Ukraine | ||
20 min | Discussion and rebuttals | ||
15 min | Coffee Break | ||
1 hour | Debate: Whether VNS therapy is alternative to other methods of surgical treatment in pharmacoresistant epilepsy? | ||
Capsule: About 30% of patients epilepsy is remained resistant to therapy. Application of VNS and other surgical methods in a number of cases allows to overcome resistance. Whether can replace application of VNS other methods of surgical treatment | |||
10 min | Debate host: Konrad Rejdak, Poland | ||
15 min | Yes: Aleksander Dukhovsky, Ukraine | ||
15 min | No: Konstantin Kostyuk, Ukraine | ||
20 min | Discussion and rebuttals | ||
1 hour | Debate: Tactics of delivery in women with epilepsy: do all women with epilepsy need operative delivery? | ||
Capsule: Epileptic seizures increase the risk of infant and maternal mortality. Many clinicians consider surgical delivery necessary. How expedient surgical delivery for all women with epilepsy? | |||
10 min | Debate host: Yurii Horansky, Ukraine | ||
15 min | Yes: Andriy Dubenko, Ukraine | ||
15 min | No: Lidya Maryenko, Ukraine | ||
20 min | Discussion and rebuttals |
foundation@rimon.in.ua
www.rimon.in.ua
Technical organizer
« Projects Inn » LLC
CONGRESS ORGANIZER AND SUPPORT / EXHIBITION CONTACT
Charitable foundation Research Innovations in Medicine “RIMON”
Ukraine, Kyiv, 01001, Business centre «Panorama»
Velyka Zhytomirska st., 20, 9 fl.
Tel/Fax: +380445375277,
E-mail: foundation@rimon.in.ua ,
www.rimon.in.ua/cony /2017